Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

INO Inovio Pharmaceuticals Inc New

1,775

-0,035 (-1,93%)

Zuletzt aktualisiert: 16:08:03

Verzögert um 15 Minuten

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Inovio Pharmaceuticals Charts.

Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Inovio Pharmaceuticals Charts.

News Inovio Pharmaceuticals Inc New

Form 8-K - Current report
Dienstag 18 März 2025 (1 Woche vor) • Edgar (US Regulatory)

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Dienstag 18 März 2025 (1 Woche vor) • PR Newswire (US)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 18 März 2025 (1 Woche vor) • Edgar (US Regulatory)

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
Donnerstag 13 März 2025 (2 Wochen vor) • PR Newswire (US)

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
Mittwoch 12 März 2025 (2 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 1 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 1 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 1 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 1 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 1 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
Mittwoch 12 Februar 2025 (1 Monat vor) • PR Newswire (US)

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
Montag 10 Februar 2025 (1 Monat vor) • PR Newswire (US)

Weitere Inovio Pharmaceuticals Inc New News-Artikel

BNP Paribas (QX)

Energy Select Sector SPDR

Gold vs US Dollar

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen